Request An Appointment
Phone

ITP (Idiopathic Thrombocytopenic Purpura)

The Gabrail Cancer Center currently has many Clinical Trial opportunities . For more information and to see if you qualify call Carrie Smith R.N., Director of Research at 330-492-3345 x 208 orĀ  via email CSmith@GabrailCancerCenter.com.

A Phase 1/2 Open-Label, Dose Escalation Study of PRTX-100 in Adult Patients with Persistent/Chronic Immune Thrombocytopenia

A Phase 1/2 Open-Label Dose Escalation Study of PRN1008 in Patients with Relapsed Immune Thrombocytopenic Purpura

 

Return to Clinical Trials at GCC